文献
J-GLOBAL ID:202202214445552734
整理番号:22A0828796
乳頭状腎細胞癌I型のフランス人患者における新規生殖系列MET病原性変異体【JST・京大機械翻訳】
Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type I
著者 (40件):
Sebai Molka
(Department of Medical Biology and Pathology, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France)
,
Tulasne David
(Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France)
,
Caputo Sandrine M.
(Department of Genetics, Institut Curie, Paris, France)
,
Caputo Sandrine M.
(Paris Sciences Lettres Research, Paris University, Paris, France)
,
Verkarre Virginie
(Department of Pathology, Georges Pompidou European Hospital, Assistance Publique Hopitaux de Paris, Paris, France)
,
Verkarre Virginie
(French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hopital Bicetre, Le Kremlin-Bicetre, France)
,
Fernandes Marie
(Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France)
,
Guerin Celia
(Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France)
,
Reinhart Fanny
(Department of Pathology, Georges Pompidou European Hospital, Assistance Publique Hopitaux de Paris, Paris, France)
,
Adams Severine
(Department of Medical Biology and Pathology, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France)
,
Maugard Christine
(Department of Molecular Oncogenetics, Hopitaux Universitaires de Strasbourg, Strasbourg, France)
,
Caron Olivier
(Department of Medical Oncology, Gustave Roussy, Villejuif, France)
,
Guillaud-Bataille Marine
(Department of Medical Biology and Pathology, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France)
,
Berthet Pascaline
(French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hopital Bicetre, Le Kremlin-Bicetre, France)
,
Berthet Pascaline
(Oncogenetics Department, Centre Francois Baclesse, Caen, France)
,
Bignon Yves-Jean
(French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hopital Bicetre, Le Kremlin-Bicetre, France)
,
Bignon Yves-Jean
(Oncogenetics Department, Centre Jean-Perrin, Clermont-Ferrand, France)
,
Bressac-de Paillerets Brigitte
(Department of Medical Biology and Pathology, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France)
,
Bressac-de Paillerets Brigitte
(French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hopital Bicetre, Le Kremlin-Bicetre, France)
,
Burnichon Nelly
(French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hopital Bicetre, Le Kremlin-Bicetre, France)
,
Burnichon Nelly
(Genetics Department, AP-HP, Hopital Europeen Georges Pompidou, Universite de Paris, Paris, France)
,
Chiesa Jean
(Department of Cytogenetics, Nimes University Hospital, Nimes, France)
,
Giraud Sophie
(French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hopital Bicetre, Le Kremlin-Bicetre, France)
,
Giraud Sophie
(Genetics Department, Hospices Civils de LYON (HCL), Lyon, France)
,
Lejeune Sophie
(French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hopital Bicetre, Le Kremlin-Bicetre, France)
,
Lejeune Sophie
(Department of Genetics, CHRU Lille, Lille, France)
,
Limacher Jean-Marc
(Genetics Department, Hopitaux Civils de Colmar, Colmar, France)
,
de Pauw Antoine
(Department of Genetics, Institut Curie, Paris, France)
,
de Pauw Antoine
(Paris Sciences Lettres Research, Paris University, Paris, France)
,
Stoppa-Lyonnet Dominique
(Department of Genetics, Institut Curie, Paris, France)
,
Stoppa-Lyonnet Dominique
(INSERM U830, Institut Curie Paris, Paris, France)
,
Stoppa-Lyonnet Dominique
(Genetics, Paris-University, Paris, France)
,
Zattara-Cannoni Helene
(French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hopital Bicetre, Le Kremlin-Bicetre, France)
,
Zattara-Cannoni Helene
(Department of Genetics, Hopital de la Timone Enfants, Marseille, France)
,
Deveaux Sophie
(French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hopital Bicetre, Le Kremlin-Bicetre, France)
,
Lidereau Rosette
(Department of Genetics, Institut Curie, Paris, France)
,
Richard Stephane
(French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hopital Bicetre, Le Kremlin-Bicetre, France)
,
Richard Stephane
(EPHE, UMR 9019 CNRS, Gustave Roussy, Paris-Saclay University, Villejuif, France)
,
Rouleau Etienne
(Department of Medical Biology and Pathology, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France)
,
Rouleau Etienne
(French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hopital Bicetre, Le Kremlin-Bicetre, France)
資料名:
Human Mutation
(Human Mutation)
巻:
43
号:
3
ページ:
316-327
発行年:
2022年
JST資料番号:
W2601A
ISSN:
1059-7794
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)